Author

Siobhan K. McRee

Observed name: Siobhan McRee

Institution: ORIC Pharmaceuticals, Inc. (United States)

Observed institutions: Tufts University, Koch Institute for Integrative Cancer Research At MIT, ORIC Pharmaceuticals, Inc. (United States), Massachusetts Institute of Technology

ORCID: 0000-0002-1539-2946

Observed ORCID: 0000-0002-1539-2946

OpenAlex ID: A5031074566

Multiplexed DNA repair assays for multiple lesions and multiple doses via transcription inhibition and transcriptional mutagenesis

2014 · Zachary D. Nagel, Carrie M. Margulies, et al. · Proceedings of the National Academy of Sciences · 170

Genome-wide single-cell-level screen for protein abundance and localization changes in response to DNA damage in S. cerevisiae

2013 · Aprotim Mazumder, Laia Quiros Pesudo, et al. · Nucleic Acids Research · 43

AKT1 Is Required for a Complete Palbociclib-Induced Senescence Phenotype in BRAF-V600E-Driven Human Melanoma

2022 · Abraham L. Bayer, Jodie Pietruska, et al. · Cancers · 10

AKT2 Loss Impairs BRAF-Mutant Melanoma Metastasis

2023 · Siobhan K. McRee, Abraham L. Bayer, et al. · Cancers · 9

Genomic Phenotyping by Barcode Sequencing Broadly Distinguishes between Alkylating Agents, Oxidizing Agents, and Non-Genotoxic Agents, and Reveals a Role for Aromatic Amino Acids in Cellular Recovery after Quinone Exposure

2013 · J. Peter Svensson, Laia Quirós Pesudo, et al. · PLoS ONE · 2

Abstract 594: ORIC-613, a potential first- and best-in-class, orally bioavailable, potent and selective PLK4 inhibitor with synthetic lethality in TRIM37 high cancer models

2024 · Kyle A. Edgar, Siobhan McRee, et al. · Cancer Research · 1

Abstract PR14: Defining isoform-specific roles for AKTs in BRAFV600E-driven melanoma

2020 · Jaymes Farrell, Jodie Pietruska, et al. · Cancer Research · 1

Abstract 4998: Selective PLK4 inhibition demonstrates synthetic lethality in TRIM37 amplified neuroblastoma and breast cancer models while less selective inhibitors do not

2023 · Siobhan K. McRee, Chelsea Chen, et al. · Cancer Research

Abstract 1112: AKT2 loss impairs BRAF mutant melanoma metastasis

2018 · Siobhan K. McRee, Jodie R. Pietruska, et al. · Cancer Research

Abstract B07: Differential roles for AKT isoforms in BRAF mutant melanoma

2017 · Siobhan K. McRee, Jodie R. Pietruska, et al. · Clinical Cancer Research

Works count: 10

Citation count: 236

H-index: 4

I10-index: 3